Maximal mid-expiratory flow detects early lung disease in α1-antitrypsin deficiency

Abstract

Pathological studies suggest that loss of small airways precedes airflow obstruction and emphysema in chronic obstructive pulmonary disease (COPD). Not all α ₁-antitrypsin deficiency (AATD) patients develop COPD, and measures of small airways function might be able to detect those at risk.

Maximal mid-expiratory flow (MMEF), forced expiratory volume in 1 s (FEV ₁), ratio of FEV ₁/forced vital capacity (FVC), health status, presence of emphysema (computed tomography (CT) densitometry) and subsequent decline in FEV ₁ were assessed in 196 AATD patients.

FEV ₁/FVC, FEV ₁ % predicted and lung densitometry related to MMEF % pred (r ²=0.778, p<0.0001; r ²=0.787, p<0.0001; r ²=0.594, p<0.0001, respectively) in a curvilinear fashion. Patients could be divided into those with normal FEV ₁/FVC and MMEF (group 1), normal FEV ₁/FVC and reduced MMEF (group 2) and those with spirometrically defined COPD (group 3). Patients in group 2 had worse health status than group 1 (median total St George's Respiratory Questionnaire (SGRQ) 23.15 (interquartile range (IQR) 7.09–39.63) versus 9.67 (IQR 1.83–22.35); p=0.006) and had a greater subsequent decline in FEV ₁ (median change in FEV ₁ −1.09% pred per year (IQR −1.91–0.04% pred per year) versus −0.04% pred per year (IQR −0.67–0.03% pred per year); p=0.007).

A reduction in MMEF is an early feature of lung disease in AATD and is associated with impaired health status and a faster decline in FEV ₁.